CCN2 and non-small cell lung carcinoma: Application of tested drugs (5-dAzaC and TSA) could be beneficial in NSCLC for at least two reasons: they not only enhanced the amount of CTGF transcripts and protein in NSCLC cell lines, but they also led to cell proliferation reduction.